Niche Personalization Cannformatics focuses on personalizing medical cannabis treatment using saliva-based Cannabis-Responsive biomarkers to tailor cultivar selection and dosage, presenting a strong value proposition for targeted healthcare providers, clinics, and cannabis product developers seeking precision dosing solutions.

Advisory Network With an active advisory board featuring notable figures like Montel Williams and others since 2021, there is an opportunity to leverage these connections for partnerships, speaking engagements, and pilot programs with medical cannabis advocates and patient communities.

Growing Validation Publications and conference participation (including a 2023 Scientific Reports article and 2025 symposium presence) indicate increasing scientific validation and visibility, signaling readiness for collaborations with research institutions, clinical researchers, and payer studies.

Healthcare Alignment The platform targets dementia and autism-related cannabis use and broader therapeutic areas, suggesting sales opportunities with neurology, pediatrics, and behavioral health clinics exploring cannabis-based interventions and personalized dosing protocols.

Lean Scale Advantage Small team size (2-10 employees) combined with existing cloud and modern tech stack implies agility for pilot programs, direct-to-client demonstrations, and scalable alliances with larger contract manufacturers or labs seeking biomarker-enabled customization.